ScinoPharm reports no impact on operations on February 6 Earthquakes

 

ScinoPharm (TWSE:1789) today announced that the 6.4-magnitude earthquake struck an area in the island’s southwest at 3:57 a.m. on February 6, 2016 did not cause any personnel injuries nor any structural or facility damage. The Company, located in the Tainan Science Park, is operating normally.

 

About ScinoPharm

ScinoPharm Taiwan, Ltd. is a leading process R&D and API manufacturing service provider to the global pharmaceutical industry. With research and manufacturing facilities in both Taiwan and China, ScinoPharm offers a wide portfolio of services ranging from custom synthesis for early phase pharmaceutical activities for brand companies as well as APIs for the generic industry. The Company also is aggressively pursuing a vertically integrated, one-stop-shopping service for drug product customers by expanding into the field of sterile oncological injectable formulations. For more information, please visit the Company's website at http://www.scinopharm.com

 

CONTACT:

Sabrina Wu

Corporate Communications Manager

TEL: +886-6-508-2869

Mobile Phone: +886-920-056-385

Email: sabrina.wu@scinopharm.com